Global HIV News
Prevention 06/01/2009
ESTEVE and IRSICAIXA sign partnership agreement for the development of a vaccine aimed to eradicate AIDS in the next 10 years
Spain leads the most important and ambitious EU research fight AIDS project.
Treatment 06/01/2009
Study links diet to health in HIV positive men
One of the hallmarks of untreated HIV/AIDS is unintentional weight loss, or wasting. Unintentional weight loss can still be a problem for some people even with the availability of HAART.
Treatment 06/01/2009
Switching from suppressive protease inhibitor-based to nevirapine-based regimens: a meta-analysis
Two studies in the meta-analysis reported significant improvement of quality of life in patients receiving nevirapine compared with those on PI-based therapy.
Treatment 06/01/2009
Lack of perceived need for HIV treatment associated with poor adherence
Patients who do not think they need antiretroviral therapy have poorer adherence to such treatment.
Prevention 06/01/2009
Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report.
Our Latest News
ECAB Meeting Calendar 05/12/2008
ECAB MEETING
Press Releases 24/11/2008
The European AIDS Treatment Group (EATG) welcomes the Joint Resolution on HIV/AIDS early diagnosis and early care and calls for Council Conclusions
21.11.2008 - EATG welcomes the resolution adopted by the European Parliament on Nov 20th. The resolution – if reflected in Council Conclusions - could be instrumental in
Open letters 12/11/2008
Joint open letter to Commissioner Vassiliou on pharmaceutical package
Dear Ms. Vassiliou,
As representatives of a wide range of organisations of patients, consumers, health professionals and social health insurances, we would like to convey you with all our trust and support. We have every confidence that you will protect public health interests when discussing the forthcoming "pharmaceutical package".
Welcome to the EATG
Established in 1992, the European AIDS Treatment Group (EATG) is an European network of nationally-based activists. As an European patient-led advocacy organisation, it has been at the forefront of the development of the civil society response to the HIV/AIDS epidemic in Europe. It represents and defends the treatment-related interests of people living with HIV and AIDS.
The EATG’s mission is to achieve the fastest possible access to state of the art medical products, devices and diagnostic tests that prevent or treat HIV infection or improve the quality of life of people living with HIV, or who are at risk of HIV infection.
In responding to HIV, the EATG also considers diseases frequently seen as co-infection in people with HIV, as well as other health issues that increase the risk of HIV.
